Is PODD a good stock to buy? We came across a bullish thesis on Insulet Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PODD. Insulet Corporation's share was trading at $159.61 as of June 9th. PODD’s trailing and forward P/E were 37.30 and 25.71 respectively according to Yahoo Finance.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. PODD is positioned as a high-quality, long-duration compounder in diabetes...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.